Listen "Updated FDA Recognition of CLSI Breakpoints (JCM ed.)"
Episode Synopsis
Oversight and guidance for performing antibiotic susceptibility testing can be bewildering. There is an alphabet soup of agencies and bodies involved: FDA, CLSI, and USCAST, to name a few here in the US. How does the Food and Drug Administration, which has regulatory authority over AST, work with a nimble group like the Clinical Laboratory Standards Institute? Guests: Romney Humphries, Ph.D., D(ABMM), M(ASCP) Patricia Simner, Ph.D., D(ABMM) Links: Major updates to FDA-recognized Clinical and Laboratory Standards Institute breakpoints are a win for the fight against antimicrobial resistance Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. Attend ASM Microbe This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro. Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro
More episodes of the podcast Editors in Conversation
Metabolomics
20/11/2025
What Makes a Great Mini-review? (JCM ed.)
29/09/2025
Emerging Technologies for Rapid Phenotypic AST of Clinical Isolates of Bacteria (JCM ed.)
17/09/2025
The Rise of Measles (AAC ed.)
28/08/2025
Show Me the Light! Uv Light for Cyclospora
04/04/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.